Daniella Beckman

CIK 1513422 · Chief Financial Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.71M

Companies

7

Total Filings

32

Lifetime Open-Market Net

-$198.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UPB Director $6.10 $0 3 2026-06-11
TNGX Chief Financial Officer 184,410 $30.94 $5.71M -$198.7K 8 2026-02-04
Blueprint Medicines Corp (BPMC) Delisted Director 10,842 $129.46 $1.40M $0 6 2025-07-21
VOR Director $14.36 $0 5 2025-05-23
TBIO Director $0.00 $0 4 2021-09-14
5:01 Acquisition Corp. (FVAM) Delisted Director $10.00 $0 1 2020-10-20
IDENIX PHARMACEUTICALS INC (IDIX) Delisted SVP, CFO and Treasurer $0 5 2014-08-05

Recent Filings · Page 4 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-03-02 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Grant (A) $0 EDGAR
2011-06-03 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Grant (A) $0 EDGAR
Showing 3132 of 32
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.